PT - JOURNAL ARTICLE AU - HU, BOBIN AU - WEI, LU AU - LIANG, HENGKAI AU - SU, MINGHUA AU - WANG, RONGMING AU - SU, TUMEI AU - LI, QINGMEI AU - YIN, QIANBING AU - FENG, YANFEI AU - JIANG, JIANNING TI - Correlation Between Serum ESPL1 and Hepatitis B Virus-related Hepatocellular Carcinoma Histological Grade: A Chinese Single-center Case-control Study AID - 10.21873/anticanres.16587 DP - 2023 Sep 01 TA - Anticancer Research PG - 3997--4005 VI - 43 IP - 9 4099 - http://ar.iiarjournals.org/content/43/9/3997.short 4100 - http://ar.iiarjournals.org/content/43/9/3997.full SO - Anticancer Res2023 Sep 01; 43 AB - Background/Aim: Serum markers to determine the histological grade of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) are still limited. This study aimed to investigate if serum extra spindle pole bodies-like 1 (ESPL1) protein could reflect the histological grade of HBV-related HCC. Materials and Methods: A total of 154 patients with HBV-related HCC were enrolled in the experimental group and 41 non-HBV-related patients in the control. Enzyme-linked immunosorbent assay was used to detect serum ESPL1 levels. The differences in serological ESPL1, alpha-fetoprotein (AFP), and des-gamma-carboxy prothrombin (DCP) were compared between the two groups. HCC tumor diameter was measured, and pathological examination was performed to compare the relationship between ESPL1, AFP, and DCP and tumor size and histological grade. Results: Serum AFP and DCP levels showed no significant difference between experimental group and control group, and increased when the tumor diameter increased but were not related to HCC histological grade. Serological ESPL1 levels were higher in the experimental group than those in the control group, and positively correlated with the histological grade. In the experimental group, tumor size and histological grade were almost independent (Kappa=0.000); patients with medium size tumors had the highest serum ESPL1 levels and the highest proportion of poorly differentiated carcinomas, whereas 75.6% of patients with small size tumors had moderately differentiated carcinomas and only 20% well differentiated carcinomas. Conclusion: Serum ESPL1 can reflect the malignant degree of HBV-related HCC and is helpful in identifying small size HCC tumors.